News and events

New research has found that every year, almost 400,000 Australians are failing to access cardiac rehabilitation programs following conditions like a heart attack, despite strong evidence that doing so significantly reduces the risk of dying from

Monash University and Monash Health yesterday hosted the Monash Women’s and Children’s Health Summit 2026, a special event bringing together over 300 of Australia’s leading researchers, clinicians, policymakers, and sector partners

The Victorian Heart Hospital and the Victorian Heart Institute will lead a first-in-human clinical trial of a new investigational genetic therapy that aims to lower cholesterol in people at increased risk of cardiovascular disease.

New research from Monash University, the University of São Paulo and Deakin University shows a diet high in heavily processed foods can negatively impact the brain’s ability to focus and increases the risk of developing dementia.

A medication commonly used to treat gout could be the key to reducing a cardiovascular condition that puts one in five people aged over 75 at risk of devastating complications like leg ulcers, gangrene and amputation.

A new study by Monash researchers has found that age-related loss of the Y chromosome from circulating blood cells may represent an under-recognised biological signal associated with myocardial infarction risk in older men. The study was published

Monash University’s Professor Dominique Cadilhac has been named joint recipient of the 2025 Australian Cardiovascular Alliance (ACvA) Excellence in Cardiovascular Research Mentor Award.

Australians undergoing open-heart surgery may soon benefit from safer, simpler care thanks to a new $3.7 million Medical Research Future Fund grant awarded to researchers from Monash University’s Victorian Heart Institute. Co-designed with

Dr Rosanne Freak-Poli, Department of Medicine, School of Clinical Sciences at Monash Health, is helping build the evidence and infrastructure for social prescribing in Australia.